Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion
Oct 13 (Reuters) -- Zealand Pharma and Generate Biomedicines said on Tuesday they have partnered to develop protein-based treatments for obesity and other metabolic diseases using…
